Michael D Green

Green Lab @ Michigan | Translational Oncology

[Michael D Green @_Beam_On]

@KamyaSankar @ReckampK @CSCancerCenter So deserved!

[Michael D Green @_Beam_On]

Huge shoutout to the collaborative team from Michigan who worked on this including Gaopeng Li, Weiping Zou, and @ArulChinnaiyan ! Let us know what you think!

[Michael D Green @_Beam_On]

Does immunotherapy help all cancer patients?

At least in a subset of patients and preclinical models, immune checkpoint blockade can cause hyperprogression of cancer. Paper out now in: @Cancer_Cell https://t.co/PQNTpbrNnU 👇

[Michael D Green @_Beam_On]

@HenningWillers @JulieSchwarz14 @KimpleRandall @DKirschMDPhD @TeWilliamsMD @ranjitbindra @CancerConnector @GeneCollector @theabzlab Yes, I write protocols and yes, we should translate our findings! I think we have unique perspective that is valuable for trial design.

[Andrew Chow @AndrewChowMDPhD]

Leveraging CD39 To Identify Tumor-Reactive CD8 T cells In Human Lung Cancer https://t.co/U0ABIPoiNP (1/6)

[Chelsea C Pinnix MD PhD @ChelseaPinnix]

The @RadiumSociety is honored to award The Janeway Medal to @PierceLoriJ! Since 1933, ARS has sponsored a lecture in memory of Dr.Henry Janeway (1873-1921). Join us virtually at the ARS annual meeting for her talk! #shatterceilings #breakbarriers @sueyom

[Beth Moore @bmoore_beth]

Spread the word! We are hiring!

[Michael D Green @_Beam_On]

Beautiful translational work on how tissue resident macrophages suppress antitumor immunity by Andrew Chow and colleagues!

[Ludwig Cancer @Ludwig_Cancer]

A study out of Ludwig @sloan_kettering reports in @Cancer_Cell how immune cells known as macrophages in body cavities can aid tumor growth by distracting CD8+ T-cells from their anti-tumor duties using a receptor the former cells express named Tim-4. https://t.co/2WeBVwDRuj

[Jason Sheltzer @JSheltzer]

New paper from @joans and me! A pan-cancer, cross-platform analysis identifies >100,000 genomic biomarkers for cancer outcomes. Plus, a website to explore the data (https://t.co/20fFzSgSEu) and a (controversial?) discussion of “cause” vs. “correlation” in cancer genome analysis.

[WashU Medicine @washumedicine]

#WashUMed radiation oncology professor @carmenbergom, MD, PhD, will receive the 2021 Michael Fry Research Award from the @RRS_RadRes for her work using genetic models to improve the effectiveness of radiation therapy. Congratulations!

https://t.co/c7K3bV7lAf

[Michael D Green @_Beam_On]

Well deserved, congrats to both of you!

[Leo Lei, DDS, PhD @LeoLeiDDSPhD]

Karen @karenmcl13 and I started our labs at the same time @UMRogelCancer and we are promoted to Associate Professors with tenure in the same cycle. Trainees are now faculty or at IO industry! Collaboration and innovation are the cornerstones of Michigan value! Thank you @wgiannob

[Michael D Green @_Beam_On]

@MelanomaReAlli @UMich So grateful for your support to run this clinical trial! @UMRogelCancer

[Lyssiotis Lab @LyssiotisLab]

Master class in brain cancer (#GBM, #DIPG) #tumormetabolism and #radiation from @DanWahlMD, @UMichRadOnc at @UMRogelCancer Grand Round! Breathtaking amount of research and clinical progress. Way to go Dan and Wahl Lab!!

[Shah Lab @YatrikShahLab]

Find out how we can selectively kill HIF2 expressing colon cancer cells.
Awesome work by @rashi_singhal7, and thanks to all of the collaborators @LyssiotisLab @KenOliveLab , #Ruma Banerjee. @UMRogelCancer @UMPhysiology @jclinicalinvest

https://t.co/7rHrl65QVt

[Michael D Green @_Beam_On]

@MelanomaReAlli So incredibly thankful for @MelanomaReAlli 's support to run a clinical trial to help cutaneous and uveal melanoma patients with liver metastases!

[JAMA Oncology @JAMAOnc]

NRG-BR001 is an NCI-sponsored phase 1 trial of SBRT for oligometastatic lesions in pts w/#BreastCancer, #ProstateCancer, or #NSCLC, which revealed no dose-limiting toxicities & encouraging median OS of 2 yrs https://t.co/wnnrl6pRSl #RadOnc

[David Braun @BraunMDPhD]

1/ Happy to share our latest work out today in @Cancer_Cell – a single-cell dissection of the kidney cancer immune microenvironment that uncovers important immune circuitry in advanced disease stages @DanaFarber @DanaFarberNews @harvardmed @broadinstitute
https://t.co/cNdLbA7AH9

[Michael D Green @_Beam_On]

@AshaniTW Meredith Morgan at University of Michigan does great DDR work!

[Kai @bmassutis]

Acquired resistance increases over time in lung cancer treated with Anti PD-(L)1 agents ⁦@myESMO⁩ ⁦@OncoAlert⁩ #ELCC21

[Michael D Green @_Beam_On]

@bmoore_beth @UMMicroImmuno Truly a dynamo! Congratulations!